ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Insider	Title	Transaction Type	Shares Traded	% of Shares Traded	% Chg. in Shares	End of Filing Shares	Price	Transaction Value	Filing Date	Transaction Date
Peter C. Farrell	Founder, Chair Emeritus & Non-Executive Director Show All	Automatic Disposition (Automatic Disposition)	-2.0K	-0.001372%	-2.8%	68.2K	251.5 - 251.5	-502.9K	04 Dec 2025	03 Dec 2025 - 03 Dec 2025
Peter C. Farrell	Founder, Chair Emeritus & Non-Executive Director Show All	Sale	-2.0K	—	—	—	251.4 - 251.4	-502.9K	03 Dec 2025	03 Dec 2025 - 03 Dec 2025
Michael J. Rider	Chief Legal Officer & Secretary Show All	Automatic Disposition (Automatic Disposition)	-50.0	-0.000034%	-0.5%	9.8K	244.2 - 244.2	-12.2K	02 Dec 2025	01 Dec 2025 - 01 Dec 2025
Brett A. Sandercock	Chief Financial Officer Show All	Automatic Disposition (Automatic Disposition)	-1.0K	-0.000685%	-1.1%	87.5K	244.2 - 244.2	-244.2K	02 Dec 2025	01 Dec 2025 - 01 Dec 2025
Brett A. Sandercock	Chief Financial Officer Show All	Sale	-1.0K	—	—	—	244.2 - 244.2	-244.2K	01 Dec 2025	01 Dec 2025 - 01 Dec 2025
Michael J. Rider
Michael J. Farrell
Peter C. Farrell
Jan De Witte
Nicole Mowad-Nassar
Jan De Witte
Justin Leong
John B. Hernandez
Nicole Mowad-Nassar
Desney Tan
Harjit Gill
Karen Ruth Drexler
Carol J. Burt
Ronald R. Taylor
Brett A. Sandercock
Michael J. Farrell
Michael J. Farrell
Christopher J. DelOrefice
Jan De Witte
Peter C. Farrell
Peter C. Farrell
Peter C. Farrell
Harjit Gill
Peter C. Farrell
Peter C. Farrell